Methamphetamine Learning Induces Persistent and Selective Nonmuscle Myosin II-Dependent Spine Motility in the

Erica J Young1,2, Hua Lin1, Theodore M Kamenecka1

  • 1Departments of Molecular Medicine, and.

Insights

Inhibiting nonmuscle myosin II (NMII) in the basolateral amygdala disrupts methamphetamine (METH) memories by affecting synaptic actin dynamics. This disruption persists long after METH use, offering a potential target for addiction treatment.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Addiction Research

Background:

  • Methamphetamine (METH) addiction is a significant public health issue with no FDA-approved pharmacotherapies.
  • METH-associated memories drive relapse, and these memories are uniquely vulnerable to disruption.
  • Nonmuscle myosin II (NMII) plays a role in synaptic plasticity and memory, but its specific role in METH-associated memory vulnerability is unclear.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the selective vulnerability of METH-associated memories to NMII inhibition.
  • To determine if METH-associated learning perpetuates NMII-driven actin dynamics in synapses, creating an extended window for memory disruption.

Main Methods:

  • Time-lapse two-photon imaging of dendritic spine motility in mouse brain slices after METH-associated learning.
  • Inhibition of NMII in the basolateral amygdala (BLA) and dorsal hippocampus (CA1) to assess memory disruption.
  • Systemic administration of an NMII inhibitor.

Main Results:

  • METH-associated learning persistently increased spine motility in the BLA, but not CA1, indicating sustained NMII-driven actin dynamics.
  • NMII inhibition in the BLA, but not CA1, selectively disrupted METH-associated memories.
  • Systemic NMII inhibition reversed METH-induced changes in BLA spine dynamics.

Conclusions:

  • Spine actin dynamics can persist for days after stimulation, controlled by NMII.
  • Perpetual NMII-driven spine actin dynamics in BLA neurons may underlie the unique susceptibility of METH-associated memories to disruption.
  • Targeting NMII in the BLA offers a potential strategy for treating METH addiction by disrupting relapse-driving memories.

Related Concept Videos